CTG monitoring in secondary healthcare
Hospital visits are highly stressful for women with high-risk pregnancies, particularly if the visit has not been scheduled in advance and the woman has to make all sorts of last-minute arrangements. It has been established that this type of stress and hassle affects the unborn child’s heart rate and the mother’s blood pressure: these would likely be lower if the pregnant woman were in the more familiar and relaxed home environment or if the tests were performed by a primary-care physician. This was one of the key drivers behind the development of Sense4Baby.
Avoid hospital appointments and overnight stays
Sense4Baby gives healthcare practitioners the opportunity to monitor patients remotely. The mother-to-be can perform CTGs at home and transmit the data to the cloud. The gynaecologist or specialised nurse can then check the data in real-time or at a later stage and contact the patient if there is a need for medical intervention. This makes it possible to avoid frequent hospital visits and even overnight stays. Sense4Baby allows pregnant women to perform all tests typically performed in the hospital right from their home. This minimises stress and means there is no need for expectant mothers to disrupt their peaceful family life and everyday routines, which benefits both mother and child.
Data securely stored in the cloud
Sense4Baby transmits all data to a securely protected cloud. A link can then be created from the cloud to the Hospital Information System (HIS) or Electronic Patient Record (EPR), giving physicians access to the data either through a web portal or the HIS or EPR.
The business case for telemonitoring
Practitioners in a growing number of medical disciplines are switching to telemonitoring their patients. In addition to offering various patient benefits, there is also a strong business case to be made for telemonitoring: it reduces the number of hospital visits and occupant days. The Dutch Hospitals Association has calculated that the use of our service can save as much as €1550 per high-risk pregnancy. This adds up to potential annual cost savings of €5.4 million for the Netherlands as a whole. We can provide you with sample calculations, so you can find out what the business case might be for your situation.